on 10 Sep 2024
Last Applicant/ Owned by
Stærmosevej 12
Vejle Øst
DK
DK-7120
Serial Number
97702169 filed on 02th Dec 2022
Registration Number
7498367 registered on 10th Sep 2024
Correspondent Address
Julie A. Greenberg
Filing Basis
1. intent to use
Disclaimer
NO DATA
Development of pharmaceutical preparations and medicines Medicine for the treatment, prevention, or alleviation of rare and genetic diseases, cancer, precancerous diseases and benign tumors, diabetes, autoimmune diseases, inflammatory diseases, infectious diseases, neurodegenerative diseases, neuromuscular disorders, psychiatric disorders, movement disorders, extrapyramidal disorders, hyperkineti Read More
Development of pharmaceutical preparations and medicines
N/A
N/A
Medicine for the treatment, prevention, or alleviation of rare and genetic diseases, cancer, precancerous diseases and benign tumors, diabetes, autoimmune diseases, inflammatory diseases, infectious diseases, neurodegenerative diseases, neuromuscular disorders, psychiatric disorders, movement disorders, extrapyramidal disorders, hyperkinetic movement disorders, hypokinetic movement disorders, parkinsonism, Parkinson's disease, sclerosis, gastrointestinal disorders and diseases, diarrhea, metabolic diseases, inborn errors of metabolism, lysosomal storage diseases, urea cycle disorders, cardiovascular diseases, neurodevelopmental disorders, cardiometabolic diseases
N/A
N/A
No 97702169
No Service Mark
No 67718-0066
Yes
No
Yes
Yes
No
No
No
No
Status Date | Action Taken |
---|---|
10th Sep 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
10th Sep 2024 | REGISTERED-PRINCIPAL REGISTER |
25th Jun 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
25th Jun 2024 | PUBLISHED FOR OPPOSITION |
05th Jun 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
17th May 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
30th Apr 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
30th Apr 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
29th Apr 2024 | ASSIGNED TO LIE |
08th Dec 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |